Thus, pancreatic PPARα signaling appears to besignificant “in vivo” and, when PPARα is activated due toelevated fatty acid levels, as in obesity, it may contribute toglucose intolerance and β-cell dysfunction. The gene discussed is PPARA; the disease is Obesity.